Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis.
Rokutanda, Ryo
Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis. [electronic resource] - Rheumatology international Jan 2014 - 59-62 p. digital
Publication Type: Journal Article
1437-160X
10.1007/s00296-012-2633-8 doi
Adrenal Cortex Hormones--therapeutic use
Adult
Aged
Connective Tissue Diseases--drug therapy
Drug Therapy, Combination
Enzyme Inhibitors--adverse effects
Female
Humans
IMP Dehydrogenase--antagonists & inhibitors
Immunosuppressive Agents--adverse effects
Male
Middle Aged
Retrospective Studies
Ribonucleosides--adverse effects
Time Factors
Treatment Outcome
Safety and efficacy of mizoribine in patients with connective tissue diseases other than rheumatoid arthritis. [electronic resource] - Rheumatology international Jan 2014 - 59-62 p. digital
Publication Type: Journal Article
1437-160X
10.1007/s00296-012-2633-8 doi
Adrenal Cortex Hormones--therapeutic use
Adult
Aged
Connective Tissue Diseases--drug therapy
Drug Therapy, Combination
Enzyme Inhibitors--adverse effects
Female
Humans
IMP Dehydrogenase--antagonists & inhibitors
Immunosuppressive Agents--adverse effects
Male
Middle Aged
Retrospective Studies
Ribonucleosides--adverse effects
Time Factors
Treatment Outcome